MONOCRONE TECHNOLOGY AND PRODUCT DEVELOPMENT.
MONOCRONE TECHNOLOGY AND PRODUCT DEVELOPMENT.
INCLUDE:
(a) Low cost lab on chip test kids for pathogen diagnosis in blood or urine
samples. Monocrone technology company LTD in partnership with the UVRI
(Uganda Virus Research institute ), Ben Gurion University -London (UK) in final stages
of development of low cost monocrone test kits for foot and mouth disease Virus
(FMDV) and oxford University in final stages of development of quality hearing aids.
Goal: Founder Don Zayeed sayeed aka Zaidi Lubega indicated that using special
monocrone bodies that will be generated to develop low cost point of care test kits for
foot and mouth disease viruses in Africa.
(b) In partnership with the united states military research institute for infectious diseases
(USAMRIID) in Maryland, United States, Uganda Virus Research Institute (UVRI) and
Ben Gurion University. The monocrone technology Company LTD aims to
develop low cost test kits for viral hemorrhagic fevers such as COVID-19,
Ebola virus and Marburg.
(c) The Monocrone technology company LTD also aims to develop sensor
diagnosis and mobile phone based technologies, assays for low cost point of care
diagnosis of infectious diseases and none communicable diseases and this will be in
partnership with the London center for NANO Technology, LCU, and UK Hisense
project.
(d) Low cost point of care micro fluidic test devices for pathogen or environmental
pollution in water bodies .In partnership with the micro or NANO Technology.
(e) Anti-cancer drugs : Monocrone Technology company limited in partnership with
NANO Technology and united nations organization (UNO) and WHO (World Health
Organization ) pharmacology and pharmacy practice , pharmaceutical chemistry units
aims at development of anti-cancer drugs formulation.
(f) Monocrone technology for bone material scaffolds and tissue engineering
technologies, implants and dental prosthetic devices. Don Zayeed Sayeed indicated
that these will be developed in partnership with the department of biomedical
engineering harnessing biomaterial scaffolds.
(g) Anti-microbial encapsulation and anti-microbial surface coating that inhibit or
block bio film formation for microbial drug resistance.
(h) Low cost tools for mapping one’s genetic code.
(i) Monocrone particles for targeted cancer delivery. Effective use of gold monocrone
particles for targeted cancer therapies will be enhanced using monocrone anti-bodies.
